Helping Manufacturers Navigate Novel Coronavirus Variants

The FDA is developing guidance for manufacturers of diagnostics, therapeutics, and vaccines to aid their response to emerging severe acute respiratory syndrome coronavirus 2 variants, Acting Commissioner Janet Woodcock, MD, said in a statement.
Source: JAMA - Category: General Medicine Source Type: research